SEC EDGAR Filing Information

Form 4 -- Statement of changes in beneficial ownership of securities

Period of Report: 2008-12-18
Filing Date Changed: 2008-12-19
Documents: 1

SEC Accession No.
0001140361-08-028371
Filing date: 2008-12-19
Accepted: 2008-12-19 16:32:36

Table of submitted documents:

Seq	Type	Document	Size	Description
1	4	doc1.html		FORM 4
1	4	doc1.xml	4631	FORM 4

		0001140361-08-028371.txt	6613	Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Issuer) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628
609-538-8200

Mailing Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628

Clavijo James (Reporting) (0001306908)
Type: 4 | Act: 34 | File No.: 000-16929 | Film No.: 081261470

Business Address
305-534-3383

Mailing Address
1691 MICHIGAN AVE SUITE 435
MIAMI FL 33139